TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.81
+0.96 (1.41%)
Jul 2, 2026, 10:48 AM EDT - Market open
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.38 billion as of July 2, 2026. Its market cap has decreased by -48.39% in one year.
Market Cap
2.38B
Enterprise Value
2.78B
1-Year Change
-48.39%
Ranking
Category
Stock Price
$68.81
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.38B, an increase of 425.58%. That is a compound annual growth rate of 26.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.38B | -42.80% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 3.40B |
| Integer Holdings | 3.21B |
| Establishment Labs Holdings | 2.63B |
| Axogen | 2.34B |
| UFP Technologies | 2.08B |
| Butterfly Network | 2.07B |
| Neogen | 2.03B |
| NovoCure | 1.83B |